Tag: antibody discovery market industry

  • Antibody Discovery Market Size to Exceed $14.6 Billion by 2029 | Growth and Industry Trends

    Antibody Discovery Market Size to Exceed $14.6 Billion by 2029 | Growth and Industry Trends

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Antibody Discovery Market Grown from 2024 to 2025?

    In recent times, the antibody discovery market has experienced a fast-paced growth. Estimated to increase from $8.96 billion in 2024 to $9.87 billion in 2025, it will exhibit a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this expansion during the historic period include a rise in funds allocated for drug discovery, increased funding in research and development activities, and the existence of numerous healthcare research centers and academic institutions.

    What Growth Rate Is Anticipated for the Antibody Discovery Market in the Coming Years?

    In the coming years, the antibody discovery market is predicted to experience swift expansion, projected to reach $14.6 billion by 2029, with an estimated compound annual growth rate (CAGR) of 10.3%. The predicted growth within this period can be credited to a rising demand for antibody drug discovery services and platforms, a swell in funding towards novel technology development, an augmented demand for precision therapeutics and the extended use of antibodies in roles surpassing their traditional therapeutic purposes. Key trends projected within this period encompass amplified research and development endeavors, heightened demand for monoclonal antibodies, greater uptake of innovative technologies, an increased necessity for targeted therapeutics, and the evolution of groundbreaking antibody formats.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

    Who Are the Leading Companies in the Antibody Discovery Market?

    Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

    What Are the Key Drivers of the Antibody Discovery Market?

    The expansion of the antibody discovery market is anticipated to be fueled by the increasing demand for precision therapeutics. Precision therapeutics, sometimes referred to as personalized therapeutics, involve customizing medical treatment procedures and interventions to suit each patient’s distinct characteristics. This is where antibody discovery plays a critical role, as it facilitates the creation of highly targeted therapies, like monoclonal antibodies. These therapies are tailored to interact specifically and accurately with disease-related molecules or cells, leading to more effective and personalized care. For instance, in January 2023, it was reported by the Personalized Medicine Coalition, a professional membership organization based in the US, that the FDA’s Center for Drug Evaluation and Research (CDER) approved 37 novel molecular entities (NMEs) in 2022, and out of these, about 34% which accounts for 12, are identified as personalized medicines by the Personalized Medicine Coalition (PMC). Consequently, the escalating demand for precision therapeutics is projected to bolster the antibody discovery market’s growth.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp

    What Are the Key Market Segments in the Antibody Discovery Industry?

    The antibody discovery market covered in this report is segmented –

    1) By Methods: Phage Display, Hybridoma, Other Methods

    2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

    3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

    Subsegments:

    1) By Phage Display: Selection And Screening Techniques, Optimization Methods

    2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

    3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

    What Are the Latest Trends in the Antibody Discovery Market?

    Leading firms involved in the antibody discovery market are introducing trailblazing technologies such as an AI-integrated computational antibody drug discovery platform for enhancing the effectiveness and precision of antibody creation. This AI-driven platform combines artificial intelligence and computational methods to speed up the identification and optimization of therapeutic antibodies. For example, SwiftPharma BV, a company based in Belgium that innovates recombinant proteins from a distinctive plant-based system, launched an AI-guided antibody discovery platform in October 2023. It integrates artificial intelligence, massive data, machine learning, and phage display methods to swiftly predict exact and high-affinity antibody-antigen binding. Comparable to natural language processing, this technology generates a wide range of antibody variations, helping SwiftPharma to construct comprehensive antibody libraries swiftly. This sophisticated system significantly accelerates the discovery of potential antibody medicines with extraordinary speed.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

    What Are the Key Regional Markets in the Antibody Discovery Industry?

    North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13783

    This Report Delivers Insight On:

    1. How big is the antibody discovery market, and how is it changing globally?

    2. Who are the major companies in the antibody discovery market, and how are they performing?

    3. What are the key opportunities and risks in the antibody discovery market right now?

    4. Which products or customer segments are growing the most in the antibody discovery market?

    5. What factors are helping or slowing down the growth of the antibody discovery market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Antibody DiscoveryMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

    Antibody DiscoveryMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

    Discover trends, market shifts, and competitive outlooks for the antibody discovery industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    What is the Projected CAGR for the Antibody Discovery Market Size from 2025 to 2034?

    The size of the antibody discovery market has seen significant expansion recently. It is projected to increase from $8.96 billion in 2024 to $9.87 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.2%. The historical period’s growth can be tied to a boost in drug discovery investments, an escalation in research and development activities, and the existence of numerous healthcare research institutions and academic centres.

    The market for antibody discovery is forecasted to experience significant expansion in the coming years, projected to reach $14.6 billion by 2029. This growth represents a compound annual growth rate (CAGR) of 10.3%. The surge expected within the forecast period is attributable to many factors, such as the heightened requirement for antibody drug discovery services and platforms. Moreover, an increase in funding aimed at the inception of innovative technologies, a growing need for precision therapeutics, and a broadened use of antibodies outside of their traditional therapeutic roles also contribute. Key trends within this forecasted period include a rise in research and development initiatives, an increased demand for monoclonal antibodies, greater use of sophisticated technologies, elevated need for targeted therapeutics, and the invention of cutting-edge antibody formats.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

    What Are the Primary Drivers Supporting the Market Growth of the Antibody Discovery Market?

    The antibody discovery market’s expansion is expected to be fueled by an increasing demand for precision therapeutics, which aims at personalizing medical treatments based on individual patient attributes. Antibody discovery contributes significantly to this shift towards personalized treatments by enabling targeted therapies like monoclonal antibodies. These therapies are scientifically crafted to specifically and accurately interact with disease-related molecules or cells, leading to more effective personalized care. Evidence of this growth was reflected in January 2023, when, as per the Personalized Medicine Coalition, a professional membership organization in the U.S, the Center for Drug Evaluation and Research (CDER) under the Food and Drug Administration approved 37 new molecular entities (NMEs) in 2022. From these, around 34% or 12 of the 35 therapeutic NMEs were categorized as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the escalating demand for precision therapeutics is set to further propel the growth of the antibody discovery market.

    Which Primary Segments of the Antibody Discovery Market Are Driving Growth and Industry Transformations?

    The antibody discovery market covered in this report is segmented –

    1) By Methods: Phage Display, Hybridoma, Other Methods

    2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

    3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

    Subsegments:

    1) By Phage Display: Selection And Screening Techniques, Optimization Methods

    2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

    3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp

    Which Regions Are Key Players in the Growth of the Antibody Discovery Market?

    North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Most Significant Market Trends in the Antibody Discovery Market?

    Leading firms in the antibody discovery market are advancing unique technologies, such as AI-integrated computational antibody drug discovery platforms, to enhance the effectiveness and accuracy of antibody development. These platforms leverage artificial intelligence and computational methods to speed up the identification and improvement of therapeutic antibodies. For instance, SwiftPharma BV, a company from Belgium that develops recombinant proteins from a dedicated plant-based system, launched an AI-powered antibody discovery platform in October 2023. This cutting-edge tool merges artificial intelligence, big data analytics, machine learning, and phage display techniques to quickly forecast antibody-antigen binding with high specificity and high affinity. The method, similar to natural language processing tactics, develops a diverse array of antibody variations, which enable SwiftPharma to generate exhaustive antibody libraries with great efficiency. This modern system prompts the discovery of potential antibody drugs at an unprecedented rate.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

    What Parameters Are Used to Define the Antibody Discovery Market?

    Antibody discovery refers to the process of identifying and developing antibodies, which are proteins produced by the immune system to help defend the body against harmful substances, such as bacteria and viruses. Antibodies, also known as immunoglobulins, play a crucial role in the immune response by recognizing and binding to specific molecules called antigens.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13783

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How the Antibody Discovery Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)

    How the Antibody Discovery Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Major Innovations Are Driving the Accelerated Growth of the Antibody Discovery Market?

    The escalating demand for precision therapeutics is set to fuel the expansion of the antibody discovery market in the future. Also referred to as personalized therapeutics, precision therapeutics involves tailoring medical treatment plans and initiatives to suit the unique attributes of each patient. The application of antibody discovery in precision therapeutics aids in creating targeted treatments, like monoclonal antibodies, which are devised to interact specifically and accurately with molecules or cells associated with diseases for more accurate and personalized treatment. For example, the Food and Drug Administration’s Center for Drug Evaluation and Research approved 37 new molecular entities in 2022, reported by the US-based professional membership organization, the Personalized Medicine Coalition, in January 2023. Of all the 35 therapeutic New Molecular Entities, about 34% – totaling 12 of them – are recognized as personalized medicines by the Personalized Medicine Coalition. Consequently, the surging requirement for precision therapeutics is expected to boost the growth of the antibody discovery market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

    #What is the Projected CAGR for the Antibody Discovery Market Size from 2025 to 2034?

    In recent years, the size of the antibody discovery market has significantly expanded. It is projected to increase from $8.96 billion in 2024 to $9.87 billion in 2025, representing a compound annual growth rate (CAGR) of 10.2%. The historical growth is linked to increased investment in drug discovery endeavors, escalation in research and development activities, and the existence of a myriad of healthcare research facilities and academic institutions.

    Anticipations of a swift expansion are being made for the antibody discovery market size in the upcoming years. The market is set to grow to $14.6 billion by 2029 with a 10.3% compound annual growth rate (CAGR). Factors contributing to this growth during the forecast period include rising needs for antibody drug discovery services and platforms, increased financial support for developing new technologies, a growing requirement for precise therapeutics, and expanded use of antibodies beyond their traditional therapeutic uses. The forecast period also sees major trends like heightened research and development efforts, rising demand for monoclonal antibodies, greater acceptance of cutting-edge technologies, increased demand for targeted therapeutics, and the creation of new antibody formats.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13783

    What Are the Most Significant Market Trends Transforming theAntibody Discovery Market?

    In the antibody discovery market, leading corporations are working on the creation of novel technologies, such as an AI-driven computational platform for discovery of antibody drugs, with the aim of enhancing antibody development accuracy and effectiveness. The AI-based drug discovery platform leverages artificial intelligence and computational methodologies to speed up the discovery and fine-tuning of therapeutic antibodies. For example, SwiftPharma BV, a Belgian firm that creates recombinant proteins utilizing a unique plant-based system, launched an AI-powered antibody discovery platform in October 2023. The groundbreaking technology integrates artificial intelligence, machine learning, big data, and phage display techniques to rapidly pinpoint high-specificity and high-affinity interactions between antibodies and antigens. Through a process similar to natural language processing, this approach generates diverse antibody variations, allowing SwiftPharma to efficiently craft extensive antibody libraries. This advanced system significantly hastens the discovery of potential antibody drugs, breaking new ground in terms of speed.

    What Are the Top Market Players Propelling the Growth of theAntibody Discovery Industry?

    Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

    Which Primary Segments of the Antibody Discovery Market Are Driving Growth and Industry Transformations?

    The antibody discovery market covered in this report is segmented –

    1) By Methods: Phage Display, Hybridoma, Other Methods

    2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

    3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

    Subsegments:

    1) By Phage Display: Selection And Screening Techniques, Optimization Methods

    2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

    3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp

    Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Antibody Discovery Market?# Market?

    North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Antibody Discovery Market 2025, By The Business Research Company:

    Antibiotics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

    Antibiotic Free Meat Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/antibiotic-free-meat-global-market-report

    Inhaled Antibiotics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/inhaled-antibiotics-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Exploring Key Insights of the Antibody Discovery Market: Growth Prospects, Emerging Trends, and Opportunities

    Exploring Key Insights of the Antibody Discovery Market: Growth Prospects, Emerging Trends, and Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What fueled the previous growth in the antibody discovery market?

    The scale of the antibody discovery market has significantly expanded in recent times. The market is projected to increase from $8.96 billion in 2024 to $9.87 billion in 2025, reflecting an impressive compound annual growth rate (CAGR) of 10.2%. The surge in the historical period is linked to an escalation in investment within drug discovery and an enhancement in research and development activities, along with the existence of numerous healthcare research centers and academic institutions.

    What will be the antibody discovery market size in the future?

    In the coming years, the antibody discovery market is predicted to experience significant expansion. It is projected to rise to $14.6 billion in 2029, with a compound annual growth rate (CAGR) of 10.3%. The surge during the projected period is due to a heightened need for antibody drug discovery services and platforms, a sharp increase in resources for developing new technologies, and a growing demand for precision therapeutics. Additionally, the use of antibodies has extended beyond their traditional therapeutic roles. The forecast period showcases trends such as elevated research and development undertakings, a heightened demand for monoclonal antibodies, an increased embracement of new technologies, a growing requirement for targeted therapeutics, and the creation of innovative antibody formats.

    Get your antibody discovery market report here!

    https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

    What main drivers are fueling expansion in the antibody discovery market?

    The expansion of the antibody discovery market is anticipated to be driven by the increasing demand for precision therapeutics. Precision therapeutics, otherwise known as personalized therapeutics, involves tailoring medical treatment strategies and interventions to the unique attributes of each patient. Antibody discovery plays a crucial part in precision therapeutics by facilitating the creation of targeted therapies like monoclonal antibodies. These are designed to interact specifically and accurately with disease-related molecules or cells for more effective and personalized care. For instance, the US-based Personalized Medicine Coalition reported in January 2023 that the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Of these 35 therapeutic NMEs, around 34% or 12 of them were classified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the increasing demand for precision therapeutics will boost the antibody discovery market’s growth.

    What key areas define the segmentation of the global antibody discovery market?

    The antibody discovery market covered in this report is segmented –

    1) By Methods: Phage Display, Hybridoma, Other Methods

    2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

    3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

    Subsegments:

    1) By Phage Display: Selection And Screening Techniques, Optimization Methods

    2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

    3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

    Who are the dominant players expanding their reach in the antibody discovery market?

    Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

    How are evolving market trends shaping antibody discovery Strategies?

    Leading firms present in the antibody discovery market are leveraging cutting-edge innovation, such as an artificial intelligence (AI) infused computational antibody drug discovery platform, to enhance the precision and speed of antibody creation. This revolutionary AI-based computational antibody drug discovery platform employs AI alongside computational strategies to hasten the detection and optimization of therapeutic antibodies. For example, in October 2023, Belgium’s SwiftPharma BV, which specializes in creating recombinant proteins using a plant-based system, unveiled an AI-powered antibody discovery platform. This bleeding-edge solution amalgamates AI, big data, machine learning, and phage display methods to instantly forecast antibody-antigen binding with high specificity and affinity. Through adopting an approach similar to natural language processing, this platform generates a broad array of antibody variants, facilitating SwiftPharma in effectively creating ample antibody libraries. This evolved system propels the discovery of promising antibody drugs at an unparalleled pace.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13783

    Which regions are emerging as leaders in the antibody discovery market?

    North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Antibiotics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

    Antibiotic Free Meat Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/antibiotic-free-meat-global-market-report

    Inhaled Antibiotics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/inhaled-antibiotics-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How is the Antibody Discovery Market Poised for Growth: Trends and Opportunities Through 2034

    How is the Antibody Discovery Market Poised for Growth: Trends and Opportunities Through 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Predicted Annual Growth Rate of the Antibody Discovery Market Over the Coming Decade?

    In recent times, there has been a substantial expansion of the antibody discovery market size. The progression is projected from $8.96 billion in 2024 to $9.87 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. Factors such as escalating investments in drug discovery, increased funding for research and development initiatives, and the existence of multiple healthcare research institutes and academic establishments have contributed to the growth experienced in the historical period.

    Anticipated to experience quick expansion in the forthcoming years, the antibody discovery market size is projected to reach $14.6 billion in 2029 with a compound annual growth rate (CAGR) of 10.3%. The escalation during the predicted period is ascribed to the rising need for antibody drug discovery services and platforms, increased investments in the development of innovative technologies, burgeoning demand for precision therapeutics, and widening use of antibodies beyond their traditional therapeutic roles. Key trends during the forecast period comprise amplified research and development endeavors, escalating demand for monoclonal antibodies, wider adoption of cutting-edge technologies, burgeoning demand for targeted therapeutics, and the evolution of new antibody formats.

    How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the antibody discovery Market?

    The surge in demand for precision therapeutics is predicted to boost the expansion of the antibody discovery market. Personalized therapeutics, also termed as precision therapeutics, involve the tailoring of medical treatments and procedures according to the unique characteristics of every patient. The role of antibody discovery in precision therapeutics is significant as it aids the creation of targeted treatments like monoclonal antibodies, which are specifically designed to interact with disease-related cells or molecules, for a more effective and personalized patient treatment. For example, in January 2023, the Personalized Medicine Coalition, a professional membership organization in the US, reported that the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022 of which nearly 34%, or twelve, have been classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the escalating requirement for precision therapeutics is anticipated to fuel the growth of the antibody discovery market.

    Request Your Free Antibody Discovery Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

    What Are the Major Players Making an Impact in the Antibody Discovery Market’s Growth?

    Major companies operating in the antibody discovery market report are:

    • Danaher Corporation_x000D_

    • Eurofins Scientific_x000D_

    • Sartorius AG_x000D_

    • Charles River Laboratories_x000D_

    • Bruker Corporation_x000D_

    Which Upcoming Trends Are Set to Influence the Antibody Discovery Market’s Path Forward?

    Leading corporations in the antibody discovery market are paving the way with cutting-edge innovations like an AI-orientated computational antibody drug discovery platform, aimed at enhancing both productivity and accuracy in antibody development. The platform under development leverages artificial intelligence and complex computing methods to hasten the recognition and refinement of therapeutic antibodies. In a noteworthy example, the Belgium-based SwiftPharma BV, famous for its development of recombinant proteins through a distinct plant-based system, unveiled an AI-supported antibody discovery platform in October 2023. This forward-thinking solution integrates artificial intelligence, large scale data, machine learning, and phage display methodologies to swiftly predict antibody-antigen binding with high-specificity and affinity. Similar to the mechanisms of natural language processing, it produces an array of antibody variants, allowing SwiftPharma to generate inclusive antibody libraries effectively. This progressive system propels the discovery of potential antibody drugs at an unprecedented pace.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

    What Are the Key Components of the Antibody Discovery Market, and How Do Its Segments Perform?

    The antibody discovery market covered in this report is segmented –

    1) By Methods: Phage Display, Hybridoma, Other Methods

    2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

    3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

    Subsegments:

    1) By Phage Display: Selection And Screening Techniques, Optimization Methods

    2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

    3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

    What Regions Are Steering Growth in the Antibody Discovery Sector?

    North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Core Features That Define the Antibody Discovery Market?

    Antibody discovery refers to the process of identifying and developing antibodies, which are proteins produced by the immune system to help defend the body against harmful substances, such as bacteria and viruses. Antibodies, also known as immunoglobulins, play a crucial role in the immune response by recognizing and binding to specific molecules called antigens.

    Browse Through More Similar Reports By The Business Research Company:

    Antibiotics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

    Antibiotic Free Meat Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/antibiotic-free-meat-global-market-report

    Inhaled Antibiotics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/inhaled-antibiotics-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: